lapatinib has been researched along with Arthritis, Rheumatoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Çiftçi, O; Emmungil, H; Kehribar, DY; Özgen, M; Salva, E; Türkmen, NB | 1 |
| Boyce, SH; Gay, RE; Gay, S; Huber, LC; Ink, BS; Künzler, P; Michel, BA | 1 |
2 other study(ies) available for lapatinib and Arthritis, Rheumatoid
| Article | Year |
|---|---|
EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts.
Topics: Arthritis, Rheumatoid; Cells, Cultured; ErbB Receptors; Fibroblasts; Humans; Lapatinib; Matrix Metalloproteinases; Synovial Membrane; Tumor Necrosis Factor-alpha | 2022 |
Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts.
Topics: Apoptosis; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Epidermal Growth Factor; Fibroblasts; Gene Expression Regulation; Humans; Inflammation Mediators; Lapatinib; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Protein Kinase Inhibitors; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Synovial Membrane | 2008 |